Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
News
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
Cheng Yi
Company notice
Company news
Media coverage
2019,08,01
The President of the Municipal Health Promotion Association led a team to visit Cheng Yi
2019,07,17
Cheng Yi's First Ranking in China's Top 100 Pharmaceutical Industry
2019,06,22
Cheng Yi Pharmaceutical's Stable Operation and Growth Promise
2019,06,04
Introducing high-end talents to add impetus to enterprise development
2019,04,03
Strive to become a practitioner of high-quality development for private enterprises
2019,03,09
Deploy new tasks and move towards a new era
2019,03,01
Cheng Yi Pharmaceutical achieved a successful start in multiple tasks
2019,02,20
Cheng Yi Pharmaceutical is moving towards a 1 billion yuan scale enterprise
2019,01,16
One of the founders of the company, Chu Fude, passed away and donated his body
2019,01,10
Conquering the World Problem of Injection "Scored Head"
2018,12,30
Chengyi Pharmaceutical was named as Wenzhou Academician Expert Workstation
2018,11,03
Dongtou District Party Secretary Wang Jiaohu Visits Chengyi Pharmaceutical Shanghai Branch
<
1
...
8
9
10
...
16
>
Contact Us
view more